Combining population-based research and functional studies for improved understanding of cardiovascular and metabolic diseases
For the past fifteen years, I have been interested in the link between metabolic disturbances, such as obesity and insulin resistance, and the development of subclinical and clinical cardiovascular disease. My research is translational and interdisciplinary, combining population studies - specifically genomics and other -omics studies - with molecular biology using in vivo and in vitro models to reach new insights into the pathophysiology of cardiovascular disease and related conditions, identification of new biomarkers for improved risk prediction, and discovery of novel targets for drug development.
I am a Professor of Medicine at Stanford University, and my contact details are below.
Please visit my Stanford webpage to learn more about our research.